GUFIC BIOSCIENCES LIMITED Corp. Office: 1st to 4th Floor, SM House, 11, Sahakar Road, Vile Parle (East), Mumbai - 400 05 7. Tel (91-22) 67261000 Fax· (91-22) 67261068 E-mail· info@guficbio.com. CIN No. L24100MH19 84PLC033519 SO/LG/SE/JUNE /2021/GBSL June 04, 2021 To The Manager (CRD) BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 Scrip Code : 509079 Dear Sirs/Mam, To The Manager National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Symbol : GUFICBIO Sub: Outcome of the Board of Directors Meeting The Board of Directors of the Company at its Meeting held on June 04, 2021, which commenced at 4:00 p.m. and concluded at 08.10 p.m. on June 04, 2021, inter alia considered and approved the following: 1. Allotment of 1,91,14,506 Equity Shares of the Company of FV of Re. 1/- each to the Shareholders of Gufic Lifesciences Private Limited ("Transferor Company" or "GLPL") pursuant to the Scheme of Amalgamaon of Gufic Lifesciences Private Limited ('Transferor Company') with the Company ('Transferee Company') and their shareholders and creditors. Accordingly, the Paid-up Share Capital of the Company has increased from Rs. 7,78,30,000 /- (7,78,30,000 equity shares of face value of Re. 1/- each) to Rs. 9,69,44,506/- (9,69,44,506 equity shares of face value Re. 1/- each). 2. The Audited Financial Results for the quarter and financial year ended March 31, 2021. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, find enclosed herewith the said results together with, Auditors Report, Declaration of unmodified opinion, Management Report and Investor Presentation. These are also being made available on the website of the Company at www.gufic.com Regd. Off 37. First Floor. Kamala Bhavan II. S. Nit y ananad Road. Andheri ( East ) . Mumbai - 400 069 . g ufic.com
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
GUFIC BIOSCIENCES LIMITED
Corp. Office: 1st to 4th Floor, SM House, 11, Sahakar Road, Vile Parle (East), Mumbai - 400 05 7. Tel (91-22) 67261000 Fax· (91-22) 67261068 E-mail· [email protected]. CIN No. L24100MH19 84PLC033519
SO/LG/SE/JUNE /2021/GBSL
June 04, 2021
To The Manager (CRD) BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001
Scrip Code : 509079
Dear Sirs/Mam,
To The Manager National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051
Symbol : GUFICBIO
Sub: Outcome of the Board of Directors Meeting
The Board of Directors of the Company at its Meeting held on June 04, 2021,
which commenced at 4:00 p.m. and concluded at 08.10 p.m. on June 04, 2021, inter alia
considered and approved the following:
1. Allotment of 1,91,14,506 Equity Shares of the Company of FV of Re. 1/- each to theShareholders of Gufic Lifesciences Private Limited ("Transferor Company" or"GLPL") pursuant to the Scheme of Amalgamation of Gufic Lifesciences PrivateLimited ('Transferor Company') with the Company ('Transferee Company') andtheir shareholders and creditors.
Accordingly, the Paid-up Share Capital of the Company has increased from Rs. 7,78,30,000 /- (7,78,30,000 equity shares of face value of Re. 1/- each) to Rs. 9,69,44,506/
(9,69,44,506 equity shares of face value Re. 1/- each).
2. The Audited Financial Results for the quarter and financial year ended March 31,
2021. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015, find enclosed herewith the said resultstogether with, Auditors Report, Declaration of unmodified opinion, ManagementReport and Investor Presentation. These are also being made available on thewebsite of the Company at www.gufic.com
Regd. Off 37. First Floor. Kamala Bhavan II. S. Nityananad Road. Andheri (East). Mumbai - 400 069 www.gufic.com
Gu�ic is a fast-growing research based pharmaceutical company recognized for its innovative, high-quality Pharmaceuticals, Nutraceuticals, Natural/Herbal products.
Gu�ic is one of the fastest growing company among the top 100 pharma companies in India
Gu�ic is one of largest manufacturers of Lyophilized injection in India with a wide range of products in various therapy areas.
Reliable CMO service for quality products over a decade
70 + Companies
150 + Products across multiple therapy areas
One of the Largest supplier of formulations-Doxycycline, Tigecycline, Gonadotropins, Liposomal Amphotericin-B, Micafungin, Remdesivir (Served ~ 5 mn Doses)